Pancreatic Cancer Research

ResearcherUniversitat Pompeu FabraNo recent work listed

María Victoria Maliandi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5447-2343; OpenAlex author ID A5026232524. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects. Co-author DOI 10.1136/jitc-2021-003254↗
  2. AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation. Co-author DOI 10.1186/s12943-015-0413-2↗
  3. Pancreatic cancer gene therapy: from molecular targets to delivery systems. Co-author DOI 10.3390/cancers3010368↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Miriam Bazán‐Peregrino · 1 shared paper, 2021 · strength 0.10
  2. Berta Laquente · 1 shared paper, 2021 · strength 0.10
  3. Rafael Álvarez-Gallego · 1 shared paper, 2021 · strength 0.10
  4. Rocio García‐Carbonero · 1 shared paper, 2021 · strength 0.10
  5. Gabriel Capellá · 1 shared paper, 2021 · strength 0.10
  6. Manuel M. Hidalgo · 1 shared paper, 2021 · strength 0.10
  7. Joan B. Gornals · 1 shared paper, 2021 · strength 0.10
  8. Luciano Sobrevals · 2 shared papers, 2011–2015 · strength 0.09
  9. Cristina Fillat · 2 shared papers, 2011–2015 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.